摘要 |
<p>A medicine for the prevention of and/or treatments for arteriosclerosis, hypertension, cardiac diseases, kidney diseases, or cerebrovascular diseases. It comprises the following ingredients as active ingredients: (A) an angiotensin II receptor antagonist selected from the group consisting of the compound represented by the following formula (I), (I) pharmacologically acceptable esters thereof, and pharmacologically acceptable salts of these (e.g., olmesartan medoxomil); and (B) a calcium antagonist selected from the group consisting of 1,4-dihydropyridine compounds and pharmacologically acceptable salts of these (e.g., azelnidipine).</p> |